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Abstract
Background: Interfering with cell proliferation and survival is a critical role for antineoplastic drugs 
leading to cell death through induction of apoptosis. Alternative treatments with herbal extracts offer 
insights into acute myeloid leukemia (AML) therapy. Parthenolide (PTL), an extract from feverfew, 
induces apoptosis in primary human leukemia stem cells (LSCs) and bulk leukemic cell populations. 
Osteopontin (OPN) preserves cell viability in response to anticancer agents and its receptors could be 
utilized for therapeutic targeting of cancer cells. 
Methods:
for 20-24 hours for MTT assays. Apoptosis assays were performed with Annexin V-Alexa Fluor-
488/PI as Annexin V+/PI- and Annexin V+/PI+ to measure early and late apoptosis, respectively. 
Quantitative real-time PCR was used to measure OPN gene expression using the 2- method. The 
PTL treated cells were stained with FITC-CD38 antibody for flow cytometry analyses. Data were 
compared using one-way analysis of variance (ANOVA) by SPSS 19.
Results: Parthenolide inhibited growth of U937 cells with IC25 and IC50 values of 4 and 5.8 µM, 
respectively. Death induction with PTL was apoptotic. Flow cytometry showed a significant decrease 
in the percentage of CD38+ U937 cells in response to PTL. Osteopontin gene expression decreased 
in response to PTL.
Conclusions: PTL induced apoptosis and reduced OPN gene expression in U937 cells.
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Introduction
Acute myeloid leukemia (AML) is a clonal 
disorder through transformation and uncontrolled 
proliferation of myeloid progenitor cells with 
arrested differentiation (1). Leukemic stem cells 
(LSCs) are AML-initiating cells of various 
populations with different features (2, 3). Acute 
myeloid leukemia-initiating cells are identified 
immunophenotypically as CD34+ and CD38- or 
CD34+ and CD38+ (4, 5). As AML cells mature, 
CD34 expression decreases gradually while 
CD38+ increases (6, 7). Current AML treatment 
utilizes chemotherapy with cytarabine and an 
anthracycline to achieve complete remission (CR) 
(8). Most therapies target molecules involved in
